CD2 Antibody (TS2/18) - Azide and BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-22537
Clone TS2/18 was used by HLDA to establish CD designation.
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human, Rat
Applications
Block/Neutralize, CyTOF-ready, Flow Cytometry, Immunoprecipitation, Inhibition Activity, Western Blot
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG1 Clone # TS2/18
Format
Azide and BSA Free
Concentration
1.0 mg/ml
Product Summary for CD2 Antibody (TS2/18) - Azide and BSA Free
Immunogen
Human LFA-2 (CD2)
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Scientific Data Images for CD2 Antibody (TS2/18) - Azide and BSA Free
Western Blot: CD2 Antibody (TS2/18)Azide and BSA Free [NBP2-22537]
Western Blot: CD2 Antibody (TS2/18) [NBP2-22537] - (Lane1), A-431 (Lane2), K562 (Lane 3) and Raji (Lane4). 1:4000 dilution.Flow Cytometry: CD2 Antibody (TS2/18) - Azide and BSA Free [NBP2-22537]
Flow Cytometry: CD2 Antibody (TS2/18) [NBP2-22537] - Analysis of CD2 in PBMC cells (green) compared to an isotype control (blue).Western Blot: CD2 Antibody (TS2/18)Azide and BSA Free [NBP2-22537]
Western Blot: CD2 Antibody (TS2/18) [NBP2-22537] - Analysis of 25 ug of Jurkat (lane 1), CEM (lane 2) and rat thymus (lane 3) cell lysates.Applications for CD2 Antibody (TS2/18) - Azide and BSA Free
Application
Recommended Usage
Flow Cytometry
3 - 5 ug / 10^6 cells
Immunoprecipitation
1:10 - 1:500
Inhibition Activity
0.5 ug
Western Blot
0.5 - 2 ug/ml
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Format
Azide and BSA Free
Preservative
No Preservative
Concentration
1.0 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: CD2
The CD2-CD58 interaction has been shown to play a role in anti-tumor immune response, where reduced CD58 signaling is associated with immune escape of tumor cells in various hematological and lymphoid malignancies, but restoration of the signal promotes an anti-tumor response (2,5). Additionally, following cytomegalovirus (CMV) infection, CD2's binding to upregulated CD58 on CMV-infected cells is crucial for the activation and function of adaptive NK cells in the anti-viral response (2). In contrast, in situations where there is an increase in T cell and NK cell activation, like various autoimmune disorders or following organ transplant, costimulatory blockade of CD2-CD58 may be a potential therapeutic treatment approach (1). Mouse and rat xenograft models have shown that blocking the CD2 using anti-CD2 monoclonal antibodies contributes to graft survival and protects against lymphocyte infiltration and inflammatory damage (2).
References
1. Binder C, Cvetkovski F, Sellberg F, et al. CD2 Immunobiology. Front Immunol. 2020;11:1090. https://doi.org/10.3389/fimmu.2020.01090
2. Zhang Y, Liu Q, Yang S, Liao Q. CD58 Immunobiology at a Glance. Front Immunol. 2021;12:705260. https://doi.org/10.3389/fimmu.2021.705260
3. Uniprot (P06729)
4. van der Merwe PA. A subtle role for CD2 in T cell antigen recognition. J Exp Med. 1999;190(10):1371-1374. https://doi.org/10.1084/jem.190.10.1371
5. Nishikori M, Kitawaki T, Tashima M, Shimazu Y, Mori M, et al. Diminished CD2 Expression in T cells Permits Tumor Immune Escape. J Clin Cell Immunol. 2016;7:406. https://doi.org/10.4172/2155-9899.1000406
Additional CD2 Products
Product Documents for CD2 Antibody (TS2/18) - Azide and BSA Free
Product Specific Notices for CD2 Antibody (TS2/18) - Azide and BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...